Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Gladstone NOW: The Campaign
Join Us On The Journey
New findings on the APOE4 gene variant point to a potential therapeutic target for Alzheimer’s disease.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Aging Human GeneticsTrained on data spanning the human lifespan, a new tool developed at Gladstone can predict genes associated with aging and age-related diseases.
News Release Research (Publication) Cardiovascular Disease Theodoris Lab AgingIn this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan Lab